Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Christine N. Spencer(The University of Texas MD Anderson Cancer Center), Sarah Schneider(Cornell University), Laura M. Kahn(The University of Texas MD Anderson Cancer Center), Courtney W. Hudgens(The University of Texas MD Anderson Cancer Center), Robert Szczepaniak‐Sloane(The University of Texas MD Anderson Cancer Center), Lauren E. Haydu(The University of Texas MD Anderson Cancer Center), Glenn Merlino(National Institutes of Health), Miles C. Andrews(Alfred Health), Jaime Anderson(The University of Texas MD Anderson Cancer Center), Matthew C. Wong(The University of Texas MD Anderson Cancer Center), John A. McCulloch(National Cancer Institute), Elizabeth Sirmans(The University of Texas MD Anderson Cancer Center), Michael G. White(The University of Texas MD Anderson Cancer Center), Chrystia M. Zobniw(The University of Texas MD Anderson Cancer Center), Alexandria P. Cogdill(University of Pennsylvania), Khalida Wani(The University of Texas MD Anderson Cancer Center), Jason Roszik(The University of Texas MD Anderson Cancer Center), Elizabeth M. Burton(The University of Texas MD Anderson Cancer Center), Yusra B. Medik(The University of Texas MD Anderson Cancer Center), Yifan Zhou(The University of Texas MD Anderson Cancer Center), Erez N. Baruch(The University of Texas MD Anderson Cancer Center), Linghua Wang(The University of Texas MD Anderson Cancer Center), Marie Vétizou(Innate Pharma (France)), Golnaz Morad(The University of Texas MD Anderson Cancer Center), Reetakshi Arora(The University of Texas MD Anderson Cancer Center), Julie M. Simon(The University of Texas MD Anderson Cancer Center), Brooke S. Lochmann(The University of Texas MD Anderson Cancer Center), Mohamed A. Jamal(Mohammed Bin Rashid University of Medicine and Health Sciences), Richard R. Rodrigues(Frederick National Laboratory for Cancer Research), Minghao Dang(The University of Texas MD Anderson Cancer Center), Sarah B. Johnson(The University of Texas MD Anderson Cancer Center), Jiali Zheng(The University of Texas MD Anderson Cancer Center), Eva Pérez‐Guijarro, Eliza Posada(The University of Texas MD Anderson Cancer Center), Jennifer L. McQuade(The University of Texas MD Anderson Cancer Center), Beth A. Helmink(The University of Texas MD Anderson Cancer Center), Karen Clise-Dwyer(The University of Texas MD Anderson Cancer Center), Md Abdul Wadud Khan(The University of Texas MD Anderson Cancer Center), Kristi L. Hoffman(Baylor College of Medicine), Vancheswaran Gopalakrishnan(AstraZeneca (United States)), Barbara Pazdrak(The University of Texas MD Anderson Cancer Center), Jonathan H. Badger(National Cancer Institute), Christine B. Peterson(The University of Texas MD Anderson Cancer Center), Theresa Rodgers(The University of Texas MD Anderson Cancer Center), Andrey Morgun(Oregon State University), Young S. Kim(Prevention Group), Xiaotao Zhang(The University of Texas MD Anderson Cancer Center), Pierre-Olivier Gaudreau(Queen's University), Angela L. Harris(The University of Texas MD Anderson Cancer Center), Chi‐Ping Day(National Institutes of Health)
Cited by 876